Impact of worsened metabolic syndrome on the risk of dementia: A nationwide cohort study

Yen Chun Fan, Chia Chi Chou, San Lin You, Chien An Sun, Chien Jen Chen, Chyi Huey Bai

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background--The relationship of alteration of metabolic syndrome (MetS) with dementia remains unclear. The purpose of study was to evaluate the association between dynamic change in MetS status around a 5-year period and dementia. Methods and Results--The cohort study was conducted from the Taiwanese Survey on Prevalence of Hypertension, Hyperglycemia, and Hyperlipidemia in 2002, with follow-up in 2007. The sample was subsequently linked to the National Health Insurance Research Database. Participants were divided into 3 groups: persistent MetS (MetS both in 2002 and 2007); nonpersistent MetS (MetS either in 2002 or 2007); and non-MetS (MetS neither in 2002 nor 2007). Furthermore, the individuals with nonpersistent MetS were categorized as improved MetS (MetS in 2002 but not in 2007) and worsened MetS (MetS not in 2002 but in 2007). Each participant was tracked until the end of 2011 to identify the development of dementia. In total, 3458 participants aged 40 to 80 years were included. Up to 10 years and 31 741 person-years of follow-up, 76 patients developed dementia. Only a relationship was found between the nonpersistent MetS and dementia (adjusted hazard ratio=1.93; 95% confidence interval =1.17-3.19; P=0.010). Moreover, a significantly higher dementia risk was observed in patients with worsened MetS (adjusted hazard ratio=2.22; 95% confidence interval=1.32-3.72; P=0.003), but not those with persistent (P=0.752) or improved (P=0.829) MetS. Similar results were detected in participants aged ≥65 years. Conclusions--Patients with worsened MetS had an increased dementia risk during the 10-year follow-up period in a populationbased sample.

Original languageEnglish
Article numbere004749
JournalJournal of the American Heart Association
Volume6
Issue number9
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Dementia
Cohort Studies
Confidence Intervals
National Health Programs
Hyperlipidemias
Hyperglycemia

Keywords

  • Dementia
  • Improved
  • Metabolic syndrome
  • Persistent
  • Worsened

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Impact of worsened metabolic syndrome on the risk of dementia : A nationwide cohort study. / Fan, Yen Chun; Chou, Chia Chi; You, San Lin; Sun, Chien An; Chen, Chien Jen; Bai, Chyi Huey.

In: Journal of the American Heart Association, Vol. 6, No. 9, e004749, 01.09.2017.

Research output: Contribution to journalArticle

Fan, Yen Chun ; Chou, Chia Chi ; You, San Lin ; Sun, Chien An ; Chen, Chien Jen ; Bai, Chyi Huey. / Impact of worsened metabolic syndrome on the risk of dementia : A nationwide cohort study. In: Journal of the American Heart Association. 2017 ; Vol. 6, No. 9.
@article{bf417f89ab9e44b8b1baf8e45de9c934,
title = "Impact of worsened metabolic syndrome on the risk of dementia: A nationwide cohort study",
abstract = "Background--The relationship of alteration of metabolic syndrome (MetS) with dementia remains unclear. The purpose of study was to evaluate the association between dynamic change in MetS status around a 5-year period and dementia. Methods and Results--The cohort study was conducted from the Taiwanese Survey on Prevalence of Hypertension, Hyperglycemia, and Hyperlipidemia in 2002, with follow-up in 2007. The sample was subsequently linked to the National Health Insurance Research Database. Participants were divided into 3 groups: persistent MetS (MetS both in 2002 and 2007); nonpersistent MetS (MetS either in 2002 or 2007); and non-MetS (MetS neither in 2002 nor 2007). Furthermore, the individuals with nonpersistent MetS were categorized as improved MetS (MetS in 2002 but not in 2007) and worsened MetS (MetS not in 2002 but in 2007). Each participant was tracked until the end of 2011 to identify the development of dementia. In total, 3458 participants aged 40 to 80 years were included. Up to 10 years and 31 741 person-years of follow-up, 76 patients developed dementia. Only a relationship was found between the nonpersistent MetS and dementia (adjusted hazard ratio=1.93; 95{\%} confidence interval =1.17-3.19; P=0.010). Moreover, a significantly higher dementia risk was observed in patients with worsened MetS (adjusted hazard ratio=2.22; 95{\%} confidence interval=1.32-3.72; P=0.003), but not those with persistent (P=0.752) or improved (P=0.829) MetS. Similar results were detected in participants aged ≥65 years. Conclusions--Patients with worsened MetS had an increased dementia risk during the 10-year follow-up period in a populationbased sample.",
keywords = "Dementia, Improved, Metabolic syndrome, Persistent, Worsened",
author = "Fan, {Yen Chun} and Chou, {Chia Chi} and You, {San Lin} and Sun, {Chien An} and Chen, {Chien Jen} and Bai, {Chyi Huey}",
year = "2017",
month = "9",
day = "1",
doi = "10.1161/JAHA.116.004749",
language = "English",
volume = "6",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Impact of worsened metabolic syndrome on the risk of dementia

T2 - A nationwide cohort study

AU - Fan, Yen Chun

AU - Chou, Chia Chi

AU - You, San Lin

AU - Sun, Chien An

AU - Chen, Chien Jen

AU - Bai, Chyi Huey

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Background--The relationship of alteration of metabolic syndrome (MetS) with dementia remains unclear. The purpose of study was to evaluate the association between dynamic change in MetS status around a 5-year period and dementia. Methods and Results--The cohort study was conducted from the Taiwanese Survey on Prevalence of Hypertension, Hyperglycemia, and Hyperlipidemia in 2002, with follow-up in 2007. The sample was subsequently linked to the National Health Insurance Research Database. Participants were divided into 3 groups: persistent MetS (MetS both in 2002 and 2007); nonpersistent MetS (MetS either in 2002 or 2007); and non-MetS (MetS neither in 2002 nor 2007). Furthermore, the individuals with nonpersistent MetS were categorized as improved MetS (MetS in 2002 but not in 2007) and worsened MetS (MetS not in 2002 but in 2007). Each participant was tracked until the end of 2011 to identify the development of dementia. In total, 3458 participants aged 40 to 80 years were included. Up to 10 years and 31 741 person-years of follow-up, 76 patients developed dementia. Only a relationship was found between the nonpersistent MetS and dementia (adjusted hazard ratio=1.93; 95% confidence interval =1.17-3.19; P=0.010). Moreover, a significantly higher dementia risk was observed in patients with worsened MetS (adjusted hazard ratio=2.22; 95% confidence interval=1.32-3.72; P=0.003), but not those with persistent (P=0.752) or improved (P=0.829) MetS. Similar results were detected in participants aged ≥65 years. Conclusions--Patients with worsened MetS had an increased dementia risk during the 10-year follow-up period in a populationbased sample.

AB - Background--The relationship of alteration of metabolic syndrome (MetS) with dementia remains unclear. The purpose of study was to evaluate the association between dynamic change in MetS status around a 5-year period and dementia. Methods and Results--The cohort study was conducted from the Taiwanese Survey on Prevalence of Hypertension, Hyperglycemia, and Hyperlipidemia in 2002, with follow-up in 2007. The sample was subsequently linked to the National Health Insurance Research Database. Participants were divided into 3 groups: persistent MetS (MetS both in 2002 and 2007); nonpersistent MetS (MetS either in 2002 or 2007); and non-MetS (MetS neither in 2002 nor 2007). Furthermore, the individuals with nonpersistent MetS were categorized as improved MetS (MetS in 2002 but not in 2007) and worsened MetS (MetS not in 2002 but in 2007). Each participant was tracked until the end of 2011 to identify the development of dementia. In total, 3458 participants aged 40 to 80 years were included. Up to 10 years and 31 741 person-years of follow-up, 76 patients developed dementia. Only a relationship was found between the nonpersistent MetS and dementia (adjusted hazard ratio=1.93; 95% confidence interval =1.17-3.19; P=0.010). Moreover, a significantly higher dementia risk was observed in patients with worsened MetS (adjusted hazard ratio=2.22; 95% confidence interval=1.32-3.72; P=0.003), but not those with persistent (P=0.752) or improved (P=0.829) MetS. Similar results were detected in participants aged ≥65 years. Conclusions--Patients with worsened MetS had an increased dementia risk during the 10-year follow-up period in a populationbased sample.

KW - Dementia

KW - Improved

KW - Metabolic syndrome

KW - Persistent

KW - Worsened

UR - http://www.scopus.com/inward/record.url?scp=85029753099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029753099&partnerID=8YFLogxK

U2 - 10.1161/JAHA.116.004749

DO - 10.1161/JAHA.116.004749

M3 - Article

AN - SCOPUS:85029753099

VL - 6

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 9

M1 - e004749

ER -